311 related articles for article (PubMed ID: 14663610)
21. Reflections of inflections in hypertrophic cardiomyopathy.
Sherrid MV; Wever-Pinzon O; Shah A; Chaudhry FA
J Am Coll Cardiol; 2009 Jul; 54(3):212-9. PubMed ID: 19589433
[TBL] [Abstract][Full Text] [Related]
22. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy.
Henein MY; O'Sullivan CA; Ramzy IS; Sigwart U; Gibson DG
J Am Coll Cardiol; 1999 Oct; 34(4):1117-22. PubMed ID: 10520800
[TBL] [Abstract][Full Text] [Related]
23. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
24. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
25. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
[TBL] [Abstract][Full Text] [Related]
26. Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases.
Kambiré Y; Millogo GRC; Dauphin C; Lusson JR
Pan Afr Med J; 2017; 27():196. PubMed ID: 28904721
[TBL] [Abstract][Full Text] [Related]
27. Dynamic change of mitral apparatus as potential cause of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Hwang HJ; Choi EY; Kwan J; Kim SA; Shim CY; Ha JW; Rim SJ; Chung N; Kim SS
Eur J Echocardiogr; 2011 Jan; 12(1):19-25. PubMed ID: 20693545
[TBL] [Abstract][Full Text] [Related]
28. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy.
Sherrid MV; Gunsburg DZ; Moldenhauer S; Pearle G
J Am Coll Cardiol; 2000 Oct; 36(4):1344-54. PubMed ID: 11028493
[TBL] [Abstract][Full Text] [Related]
29. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip.
Schäfer U; Frerker C; Thielsen T; Schewel D; Bader R; Kuck KH; Kreidel F
EuroIntervention; 2015 Dec; 11(8):942-7. PubMed ID: 25169590
[TBL] [Abstract][Full Text] [Related]
30. Isolated right ventricular hypertrophic obstructive cardiomyopathy.
Mittal SR
J Assoc Physicians India; 2010 Apr; 58():249-50. PubMed ID: 21046883
[TBL] [Abstract][Full Text] [Related]
31. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
33. Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy.
Malcolmson JW; Hamshere SM; Joshi A; O'Mahony C; Dhinoja M; Petersen SE; Sekhri N; Mohiddin SA
Catheter Cardiovasc Interv; 2018 Mar; 91(4):783-789. PubMed ID: 28766836
[TBL] [Abstract][Full Text] [Related]
34. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.
Keng FY; Chang SM; Cwajg E; He ZX; Lakkis NM; Nagueh SF; Spencer WH; Verani MS
J Nucl Cardiol; 2002; 9(6):594-600. PubMed ID: 12466783
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
[TBL] [Abstract][Full Text] [Related]
36. Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy.
Barac I; Upadya S; Pilchik R; Winson G; Passick M; Chaudhry FA; Sherrid MV
J Am Coll Cardiol; 2007 Mar; 49(11):1203-11. PubMed ID: 17367665
[TBL] [Abstract][Full Text] [Related]
37. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS
Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886
[TBL] [Abstract][Full Text] [Related]
38. A case report of surgical septal myectomy of hypertrophic cardiomyopathy with concomitant left ventricular outflow tract and mid-ventricular obstructions.
Guler N; Ozkara C; Gumrukcuoglu HA; Simsek H
J Card Surg; 2006; 21(6):591-3; discussion 593. PubMed ID: 17073961
[TBL] [Abstract][Full Text] [Related]
39. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
Circulation; 1999 Jan; 99(3):344-7. PubMed ID: 9918519
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
